Publications

Humble G, Bassichis B,Blick Conant M, Gold M, Echavez M, Mest D, Injectable Poly-L-Lactic Acid for Human Immunodeficiency Virus-Associated Facial Lipoatrophy: Cumulative 2 Year Interim Analysis of Open Label Study (Faces)American Society for Dermatologic Surgery, INC 2012;38:1193-1205

Humble G, Mest D. Evaluation of the Cross Fanning Injection Method for Injectable Poly L-lactic acid for Treating HIV-Associated Facial Lipoatrophy

Humble G, Mest D. Retreatment with Injectable Poly-L-Lactic Acid for HIV Associated Facial Lipoatrophy: 24-Month Extension of the Blue Pacific Study. Dermatologic Surgery 2009 Vol. 35 No. 1 Sp ed. Feb 2009

Humble G, Mest D. Injection Method Review and Evaluation for Injectable Poly L-Lactic Acid for Treating HIV-Associated Facial Lipoatrophy Manuscript Submitted

Humble G, Mest D. Duration of Correction of Human Immunodeficiency Virus Associated Lipoatrophy Following Retreatment with Injectable Poly-L-Lactic Acid. Aesthetic Plastic Surgery in Press

Humble G, Mest D, Safety and Efficacy of Poly-L-Lactic Acid (Sculptra) injections in persons with HIV-Associated Lipoatrophy: The US Experience: Derm Surg 2006 32;11:1336-1345

Humble G, Mest D. Human Immunodeficiency Virus-Associated Facial Lipoatrophy: A Review: Cosmetic Dermatology 2006 19; 1:62-66

Humble G, Mest D, Englehard P. Safety of Sculptra: A Review of Clinical Trial Data Journal of Cosmetic Laser Therapy 2005

Humble G, Mest, D. Soft Tissue Augmentation Using Sculptra Facial Plastic Surgery 2004 20; 2:157-163

Humble G, Mest, D. Soft Tissue Augmentation Using Silicone: An Historical Review Facial Plastic Surgery 2004 20; 2:181-184

Humble G, Filler Offers Longevity, Hope for Lipoatrophy Cosmetic Surgery Times 2005

Humble G, Treating Lipoatrophy with New Filler A Look at Successful Patient Cases Skin & Aging 2004

Humble G, FDA Ponders Approval of New-Fill For Wrinkles, Volume Loss Dermatology Times 2003 Vol. 24 No. 9

Humble G, Mest D. Duration of Correction for Human Immunodeficiency Virus Associated Lipoatrophy After Retreatment with Injectable Poly-L-Lactic Acid. Aesthetic Plast Surg 2009 33; 4:654

Humble G, Mest D. Retreatment with injectable PLLA for HIV-Associated Facial Lipoatrophy: 24-Month Extension of the Blue Pacific Study. Dermatol Surg 2009 35:350-359

Humble G, Mest D. A Recommended Approach to Cosmetic Enhancement with Sculptra. Skin & Aging 2007; 15 (10): 60-2

Humble G, Mest D, Conant M, Burgess, C. Poly-L-Lactic Acid for Facial Contouring: clinical insights

Humble G, Mest D, Safety and Efficacy of Poly-L-Lactic Acid (Sculptra) Injections in Persons with HIV-Associated Lipoatrophy: The US Experience: Dermatol Surg 2006 32; 11:1336-1345

Humble G, Mest D, Human Immunodeficiency Virus-Associated Facial Lipoatrophy: A Review: Cosmetic Dermatology 2006 19; 1:62-66

Humble G, Mest D, Englehard P, Safety of Sculptra: A Review of Clinical Trial Data J Cosm Laser Ther 2005 7; 3-4:201-205

Humble G., Mendiola R. Utilizing the Klotho Protein and Second Generation Growth Factors for the Treatment of Facial Photoaging: A Clinical Experience with Ten Cases. Submitted to Journal of Investigative Dermatology 2022.

 Abstracts

Humble G., Mendiola R. Utilizing the Klotho Protein and Second Generation Growth Factors for the Treatment of Facial Photoaging: A Clinical Experience with Ten Cases. Submitted to Journal of Investigative Dermatology 2022.

Humble G, Mest D. Evaluation of the Cross Fanning Injection Method for Injectable Poly L-Lactic acid for Treating HIV-Associated Facial Lipoatrophy (submitted)

Humble G, Mest D, Pierone G, Injectable Poly-L-Lactic Acid for Human Immunodeficiency Virus-Related Lipoatrophy: 2-Year Interim 5 Year Study Results, Summer AAD

Humble G, Mest D, Pierone G, Injectable Poly-L-Lactic Acid for Human Immunodeficiency Virus-Related Lipoatrophy: 3-Year Interim 5 Year Study Results, Summer AAD

Humble G, Mest D, Interim Results of a 5-Year Open-Label Study for the Correction of HIV-Related Facial Lipoatrophy with Injectable PLLA SDEF Hawaii Dermatology Meeting, Maui, HI 2009

Humble G, Mest D. Safety and Efficacy of Intradermal Poly-L-lactic acid (Sculptra) injections in patients with HIV Associated Facial Lipoatrophy. Antiviral Therapy 2004; 9:L36

Humble G, Mest D. Poly L-Lactic Acid for the treatment of HIV-Associated Facial Lipoatrophy in Surgical Facial Rejuvenation: Art and Clinical Practice, Ed. Shiffman M, Springer, Berlin In Press

Humble G, Mest D. Review and Evaluation of Treatment Procedures Using Injectable Poly-L-Lactic Acid in the Treatment of HIV-Associated Facial Lipoatrophy Manuscript Submitted

Humble G, Mest D. Duration of Correction for Human Immunodeficiency Virus Associated Lipoatrophy After Retreatment with Injectable Poly-L-Lactic Acid. Aesthetic Plast Surg 2009 33; 4:654

Humble G, Mest D. Retreatment with injectable PLLA for HIV-Associated Facial Lipoatrophy: 24-Month Extension of the Blue Pacific Study. Dermatol Surg 2009 35:350-359

Humble G, Mest D. A Recommended Approach to Cosmetic Enhancement with Sculptra. Skin & Aging 2007; 15 (10): 60-2

Humble G, Mest D, Conant M, Burgess, C. Poly-L-Lactic Acid for Facial Contouring: clinical insights In Press

Humble G, Mest D, Safety and Efficacy of Poly-L-Lactic Acid (Sculptra) Injections in Persons with HIV-Associated Lipoatrophy: The US Experience: Dermatol Surg 2006 32; 11:1336-1345

Humble G, Mest D, Human Immunodeficiency Virus-Associated Facial Lipoatrophy: A Review: Cosmetic Dermatology 2006 19; 1:62-66

Humble G, Mest D, Englehard P, Safety of Sculptra: A Review of Clinical Trial Data J Cosm Laser Ther 2005 7; 3-4:201-205

Humble G, Mest D. Soft Tissue Augmentation Using Sculptra Facial Plastic Surgery 2004 20; 2:157- 163

Humble G, Mest D. Soft Tissue Augmentation Using Silicone: An Historical Review Facial Plastic Surgery 2004 20; 2:181-184

Humble G., Mendiola R. Utilizing the Klotho Protein and Second-Generation Growth Factors for the Treatment of Facial Photoaging: A Clinical Experience with Ten Cases. Submitted for AACS 2022 Conference, COSM 2022.

Humble G., Mendiola R. Abstract: Effect of AdviCell K on the Expression of a Panel of Skin. Submitted for AACS 2022 Conference, COSM 2022.

Humble G, Mendiola R. Abstract: Effect of K-Advicell on the output of Prostaglandin E2, Type I and type IV collagen by Human Dermal Fibroblasts. Submitted AACS 2022 Conference.